EP Patent

EP2210599A1 — Lidocaine tape preparation

Assigned to MedRx Co Ltd · Expires 2010-07-28 · 16y expired

What this patent protects

The present invention discloses a novel tape preparation containing lidocaine at a high concentration. A tape preparation containing lidocaine at a high content, which has a lidocaine contant of 10 w/w% or more, can be produced by using a lactic acid salt of lidocaine, while prev…

USPTO Abstract

The present invention discloses a novel tape preparation containing lidocaine at a high concentration. A tape preparation containing lidocaine at a high content, which has a lidocaine contant of 10 w/w% or more, can be produced by using a lactic acid salt of lidocaine, while preventing the precipitation of a crystal of lidocaine.

Drugs covered by this patent

Patent Metadata

Patent number
EP2210599A1
Jurisdiction
EP
Classification
Expires
2010-07-28
Drug substance claim
No
Drug product claim
No
Assignee
MedRx Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.